Age and hypoalbuminemia independently predict pulmonary consolidation in children with 23S rRNA A2063G-mutant Mycoplasma pneumoniae pneumonia: a retrospective single-center study - Scorecard - MDSpire
Advertisement
Age and hypoalbuminemia independently predict pulmonary consolidation in children with 23S rRNA A2063G-mutant Mycoplasma pneumoniae pneumonia: a retrospective single-center study
Clinical Scorecard: Independent Risk Factors for Pulmonary Consolidation in Pediatric Patients with 23S rRNA A2063G-Variant Mycoplasma pneumoniae Pneumonia: A Retrospective Study
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Children aged 28 days to <18 years with MPP and A2063G mutation
Care Setting
Key Highlights
Older age and lower albumin levels are independent risk factors for pulmonary consolidation.
Children with A2063G mutation show higher rates of pulmonary consolidation.
Elevated inflammatory markers are associated with pulmonary consolidation.
A2063G mutation is linked to reduced efficacy of macrolide antibiotics.
Guideline-Based Recommendations
Diagnosis
Management
Select appropriate antiviral agents or antibiotics based on pathogen characteristics, emphasizing the need for alternatives in resistant cases.
Supportive care including antipyretic therapy and oxygen therapy is recommended.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Macrolide antibiotics have reduced efficacy due to resistance; consider alternative treatments such as doxycycline or respiratory fluoroquinolones.
Clinical Best Practices
Early identification of high-risk patients for pulmonary consolidation is essential.
Consider glucocorticoids for severe cases only, not for all patients with consolidation.
Monitor for long-term sequelae in high-risk patients.
